Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients
- PMID: 17947464
- DOI: 10.1158/1078-0432.CCR-07-0031
Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients
Abstract
Purpose: Two pathways, hyperdiploid and nonhyperdiploid, are proposed for progression to plasma cell neoplasia. Implication of monosomy 13 (Delta13) is unclear in monoclonal gammopathy of undetermined significance (MGUS), and data on DNA content of plasma cells [DNA index (DI)] are rare.
Experimental design: We ascertained DI in 169 multiple myeloma (MM) and 96 MGUS patients. Interphase fluorescence in situ hybridization (FISH) coupled to cytoplasmic staining of specific Ig (cIg-FISH) was done to look for trisomies and to ascertain Delta13.
Results: Hyperdiploidy and hypodiploidy were found in 54% and 11.5% of MGUS patients and in 59.5% and 25% of MM patients, respectively. In MGUS patients tested using probes for odd chromosomes, cIg-FISH showed association between trisomies for chromosomes 3, 7, 9, 11, or 15 and hyperdiploidy. Delta13 was found in 45.3% and 24.6% of MM and MGUS patients, respectively. Most Delta13 cases observed in MGUS were found within hyperdiploid clones, 38% versus 11% in hypodiploid cases, in sharp contrast with the occurrence of Delta13 in MM patients, 31.9% and 76.3%, respectively. That peculiar distribution of Delta13 according to DI persisted with other thresholds used to ascertain hyperdiploidy, such as DI >or= 1.05. A strong relationship between IgA peak and hypodiploidy (P = 0.007) was only observed in MM, whereas lambda light chain was significantly associated with hypodiploidy in MGUS (P = 0.001) and MM (P = 0.05). Hyperdiploidy shows similar pattern in MGUS and MM.
Conclusion: This fits well a hyperdiploid pathway leading to MM after a preceding MGUS stage. Yet-to-be-determined secondary event(s) needs to occur for the transition to MM, unrelated to changes in chromosome number or to loss of chromosome 13. In contrast, the "nonhyperdiploid" pathway needs to be clarified further because hypodiploidy is less common in MGUS than in MM and Delta13 is rare in hypodiploid MGUS patients compared with hypodiploid MM patients.
Similar articles
-
Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.Cancer. 2003 Feb 1;97(3):601-9. doi: 10.1002/cncr.11100. Cancer. 2003. PMID: 12548602
-
Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.Cancer Genet Cytogenet. 2007 Apr 15;174(2):89-99. doi: 10.1016/j.cancergencyto.2006.11.015. Cancer Genet Cytogenet. 2007. PMID: 17452249
-
14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.Cancer Res. 1999 Sep 15;59(18):4546-50. Cancer Res. 1999. PMID: 10493504
-
Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.Pathol Biol (Paris). 1999 Feb;47(2):119-27. Pathol Biol (Paris). 1999. PMID: 10192879 Review.
-
Genetics of multiple myeloma.Best Pract Res Clin Haematol. 2005;18(4):525-36. doi: 10.1016/j.beha.2005.01.006. Best Pract Res Clin Haematol. 2005. PMID: 16026735 Review.
Cited by
-
Myeloid-derived suppressor cells: The green light for myeloma immune escape.Blood Rev. 2016 Sep;30(5):341-8. doi: 10.1016/j.blre.2016.04.002. Epub 2016 Apr 12. Blood Rev. 2016. PMID: 27132116 Free PMC article. Review.
-
Staging and prognostication of multiple myeloma.Expert Rev Hematol. 2014 Feb;7(1):21-31. doi: 10.1586/17474086.2014.882224. Expert Rev Hematol. 2014. PMID: 24483346 Free PMC article. Review.
-
Risk Stratification in Multiple Myeloma.Curr Hematol Malig Rep. 2016 Apr;11(2):137-47. doi: 10.1007/s11899-016-0307-4. Curr Hematol Malig Rep. 2016. PMID: 26883334 Review.
-
Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.Haematologica. 2009 Dec;94(12):1708-13. doi: 10.3324/haematol.2009.011064. Haematologica. 2009. PMID: 19996118 Free PMC article.
-
Immunological dysregulation in multiple myeloma microenvironment.Biomed Res Int. 2014;2014:198539. doi: 10.1155/2014/198539. Epub 2014 Jun 11. Biomed Res Int. 2014. PMID: 25013764 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous